
The agentic model is emerging as a strategic tool to compress analysis timelines, coordinate cross-functional teams and surface competitive intelligence in real time.
Is vice president, offering development within IQVIA’S global commerce offering business responsible for global launch excellence. Over the past 25 years, she has worked with some of the world’s most successful brands across both the pharma and CPG industries in Europe, the Americas, and Southeast Asia.

The agentic model is emerging as a strategic tool to compress analysis timelines, coordinate cross-functional teams and surface competitive intelligence in real time.

How drugmakers can reap value from using generative AI in their market-entry strategies and decision-making, including mitigating launch challenges and enhancing the customer conversation.

August 15th 2024